|
26
|
201
|
7f63A |
Cryo-em structure of sars-cov-2 spike in complex with a neutralizing antibody chab-45 (focused refinement of s-rbd and chab-45 region) |
|
191
|
1112
|
7fg2A |
Minor cryo-em structure of s protein trimer of sars-cov2 with k-874a vhh, composite map |
|
25
|
260
|
7ey0N |
Local cryoem structure of the sars-cov-2 s6pv2 in complex with bd-813 fab and bd-744 fab |
|
19
|
183
|
7ey4R |
Local cryoem of the sars-cov-2 s6pv2 in complex with bd-667 |
|
35
|
183
|
7ezvA |
Local cryoem structure of the sars-cov-2 s6pv2 in complex with bd-812 fab and bd-836 fab |
|
21
|
183
|
7eyaR |
Local cryoem structure of the sars-cov-2 s6pv2 in complex with bd-804 fab |
|
23
|
183
|
7ey5A |
Local cryoem structure of the sars-cov-2 s6pv2 in complex with bd-771 fab and bd-821 fab |
|
180
|
1136
|
7mm0A |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
|
226
|
1134
|
7e5rA |
Sars-cov-2 s trimer with three-antibody cocktail complex |
|
155
|
1120
|
7eh5A |
Cryo-em structure of sars-cov-2 s-d614g variant in complex with neutralizing antibodies, rbd-chab15 and rbd-chab45 |
|
126
|
1118
|
7edhA |
Cryo-em structure of sars-cov-2 s-uk variant (b.1.1.7), one rbd-up conformation 3 |
|
37
|
192
|
7e5oA |
Crystal structure of sars-cov-2 rbd in complex with antibody nt-193 |
|
178
|
1121
|
7e3kA |
Ultrapotent sars-cov-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants |
|
25
|
194
|
7e39A |
Sars-cov-2 spike in complex with the ab4 neutralizing antibody (state 3) |
|
184
|
1121
|
7e3lA |
Ultrapotent sars-cov-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants |
|
165
|
1118
|
7edgA |
Cryo-em structure of sars-cov-2 s-uk variant (b.1.1.7), one rbd-up conformation 2 |
|
167
|
1118
|
7edfA |
Cryo-em structure of sars-cov-2 s-uk variant (b.1.1.7), one rbd-up conformation 1 |
|
34
|
189
|
7e3oR |
Crystal structure of sars-cov-2 receptor binding domain in complex with neutralizing antibody ncov617 |
|
158
|
1118
|
7ediA |
Cryo-em structure of sars-cov-2 s-uk variant (b.1.1.7), two rbd-up conformation |
|
143
|
1118
|
7edjA |
Cryo-em structure of sars-cov-2 s-uk variant (b.1.1.7) in complex with angiotensin-converting enzyme 2 (ace2) ectodomain |
|
32
|
194
|
7e3bA |
Sars-cov-2 spike in complex with the ab5 neutralizing antibody (focused refinement on fab-rbd) |
|
42
|
195
|
7dhxB |
Crystal structure of sars-cov-2 rbd binding to pangolin ace2 |
|
36
|
195
|
7drvC |
Structural basis of sars-cov-2-closely-related bat coronavirus ratg13 to hace2 |
|
29
|
193
|
7cyvB |
Crystal structure of fd20, a neutralizing single-chain variable fragment (scfv) in complex with sars-cov-2 spike receptor-binding domain (rbd) |
|
52
|
207
|
7coeA |
Crystal structure of receptor binding domain of mers-cov and knih90-f1 fab complex |
|
23
|
201
|
7f62A |
Cryo-em structure of sars-cov-2 spike in complex with a neutralizing antibody chab-25 (focused refinement of s-rbd and chab-25 region) |
|
33
|
194
|
7e3cA |
Sars-cov-2 spike in complex with the ab1 neutralizing antibody (focused refinement on fab-rbd) |
|
196
|
1126
|
7n9cA |
Potent neutralizing nanobodies resist convergent circulating variants of sars-cov-2 by targeting novel and conserved epitopes-covs with nb95 |
|
42
|
193
|
7s4sA |
Crystal structure of sars-cov-2 s receptor-binding domain (rbd) in complex cov11 fab |
|
193
|
1132
|
7rw2A |
Cryo-em structure of ntd-directed neutralizing antibody 5-7 in complex with prefusion sars-cov-2 spike glycoprotein |
|
197
|
1116
|
7rkvA |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c118 (state 1) |
|
39
|
196
|
7rkuA |
Structure of the sars-cov-2 receptor binding domain in complex with the human neutralizing antibody fab fragment, c022 |
|
40
|
195
|
7r8lE |
Structure of the sars-cov-2 rbd in complex with neutralizing antibody c099 and cr3022 |
|
216
|
1119
|
7ra8A |
Sars-cov-2 s glycoprotein in complex with s2x259 fab |
|
32
|
194
|
7ralB |
Sars-cov-2 s bound to s2x259 fab (local refinement of the rbd/s2x259 variable domains) |
|
175
|
1123
|
7r8nA |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c051 |
|
167
|
1117
|
7r8mA |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c032 |
|
223
|
1123
|
7r8oA |
Structure of the sars-cov-2 s 6p trimer in complex with neutralizing antibody c548 |
|
46
|
199
|
7r6xR |
Sars-cov-2 spike receptor-binding domain (rbd) in complex with s2e12 fab, s309 fab, and s304 fab |
|
37
|
193
|
7r7nE |
Sars-cov-2 spike in complex with the s2d106 neutralizing antibody fab fragment (local refinement of the rbd and s2d106) |
|
45
|
195
|
7r6wR |
Sars-cov-2 spike receptor-binding domain (rbd) in complex with s2x35 fab and s309 fab |
|
248
|
1119
|
7n8hA |
Sars-cov-2 s (b.1.429 / epsilon variant) + s2m11 + s2l20 global refinement |
|
36
|
280
|
7n8iA |
Sars-cov-2 s (b.1.429 / epsilon variant) + s2m11 + s2l20 (local refinement of the ntd/s2l20) |
|
20
|
196
|
7mlzA |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
|
17
|
196
|
7lrsC |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody a23-58.1 that targets the receptor-binding domain |
|
180
|
1136
|
7lrtA |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody a23-58.1 that targets the receptor-binding domain |
|
22
|
195
|
7m42E |
Complex of sars-cov-2 receptor binding domain with the fab fragments of neutralizing antibodies regn10985 and regn10989 |
|
37
|
195
|
7or9E |
Crystal structure of the receptor binding domain of sars-cov-2 spike glycoprotein in complex with covox-222 and covox-278 fabs |
|
40
|
185
|
7orbR |
Crystal structure of the l452r mutant receptor binding domain of sars-cov-2 spike glycoprotein in complex with covox-75 and covox-253 fabs |
|
46
|
197
|
7oraC |
Crystal structure of the t478k mutant receptor binding domain of sars-cov-2 spike glycoprotein in complex with covox-45 and covox-253 fabs |
